Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
inobrodib (CCS1477)
i
Other names:
CCS1477, CCS 1477, CCS-1477
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
CellCentric
Drug class:
CBP inhibitor, EP300 inhibitor
Related drugs:
‹
eribulin mesylate (47)
PRI724 (5)
FT-6876 (1)
AU-18069 (0)
AUR-107 (0)
E7386 (0)
EP31670 (0)
NEO1132 (0)
eribulin mesylate (47)
PRI724 (5)
FT-6876 (1)
AU-18069 (0)
AUR-107 (0)
E7386 (0)
EP31670 (0)
NEO1132 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
CCS1477
Sensitive: B - Late Trials
CCS1477
Sensitive
:
B
CCS1477
Sensitive: B - Late Trials
CCS1477
Sensitive
:
B
MYC expression
Multiple Myeloma
MYC expression
Multiple Myeloma
lenalidomide + CCS1477
Sensitive: D – Preclinical
lenalidomide + CCS1477
Sensitive
:
D
lenalidomide + CCS1477
Sensitive: D – Preclinical
lenalidomide + CCS1477
Sensitive
:
D
IRF4 expression
Multiple Myeloma
IRF4 expression
Multiple Myeloma
lenalidomide + CCS1477
Sensitive: D – Preclinical
lenalidomide + CCS1477
Sensitive
:
D
lenalidomide + CCS1477
Sensitive: D – Preclinical
lenalidomide + CCS1477
Sensitive
:
D
MYC expression
Acute Myelogenous Leukemia
MYC expression
Acute Myelogenous Leukemia
CCS1477
Sensitive: D – Preclinical
CCS1477
Sensitive
:
D
CCS1477
Sensitive: D – Preclinical
CCS1477
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login